Sign in
4/A

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046266

Options or other derivatives

  • Chief Scientific Officer acquired 15,177 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-05-23 Option exercise · Stock option (right to buy) −15,177 14,862 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…